Insulin, Semaglutide and Dapagliflozin in Adults With Type 1 Diabetes: Design and Methods of Triple Therapy for Type 1 Diabetes (TTT1)-An International Phase 3 Clinical Trial.
- DOI
- 10.1111/dom.71076
- Published
- 2026 Oct
- Container
- Diabetes, obesity & metabolism
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1111/dom.71076,
title = {Insulin, Semaglutide and Dapagliflozin in Adults With Type 1 Diabetes: Design and Methods of Triple Therapy for Type 1 Diabetes (TTT1)-An International Phase 3 Clinical Trial.},
author = {Timmons JG and Ghanim H and Boyle JG and Greenlaw N and Chaudhuri A and Batra MA and Lindsay RS and Jolly L and Bonner C and McConnachie A and Petrie JR and Dandona P},
year = {2026},
journal = {Diabetes, obesity \& metabolism},
doi = {10.1111/dom.71076},
url = {https://doi.org/10.1111/dom.71076}
}RIS
TY - JOUR TI - Insulin, Semaglutide and Dapagliflozin in Adults With Type 1 Diabetes: Design and Methods of Triple Therapy for Type 1 Diabetes (TTT1)-An International Phase 3 Clinical Trial. AU - Timmons JG AU - Ghanim H AU - Boyle JG AU - Greenlaw N AU - Chaudhuri A AU - Batra MA AU - Lindsay RS AU - Jolly L AU - Bonner C AU - McConnachie A AU - Petrie JR AU - Dandona P PY - 2026 JO - Diabetes, obesity & metabolism DO - 10.1111/dom.71076 UR - https://doi.org/10.1111/dom.71076 ER -
APA
JG, T., H, G., JG, B., N, G., A, C., MA, B., RS, L., L, J., C, B., A, M., JR, P., & P, D. (2026). Insulin, Semaglutide and Dapagliflozin in Adults With Type 1 Diabetes: Design and Methods of Triple Therapy for Type 1 Diabetes (TTT1)-An International Phase 3 Clinical Trial.. Diabetes, obesity & metabolism. https://doi.org/10.1111/dom.71076
Source records
- pubmed · retrieved 2026-09-26T11:12:39.994Z